Arcadia Biosciences, Inc. (RKDA): Price and Financial Metrics


Arcadia Biosciences, Inc. (RKDA): $2.62

-0.01 (-0.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RKDA to Watchlist
Sign Up

Industry: Agriculture


Ranked

of 30

in industry

RKDA Stock Summary

  • Of note is the ratio of Arcadia Biosciences Inc's sales and general administrative expense to its total operating expenses; 98.42% of US stocks have a lower such ratio.
  • With a year-over-year growth in debt of 317.69%, Arcadia Biosciences Inc's debt growth rate surpasses 95.75% of about US stocks.
  • As for revenue growth, note that RKDA's revenue has grown 587.25% over the past 12 months; that beats the revenue growth of 98.77% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Arcadia Biosciences Inc are WWD, NATI, EH, PSNL, and AAOI.
  • RKDA's SEC filings can be seen here. And to visit Arcadia Biosciences Inc's official web site, go to www.arcadiabio.com.

RKDA Stock Price Chart Interactive Chart >

Price chart for RKDA

RKDA Price/Volume Stats

Current price $2.62 52-week high $6.40
Prev. close $2.63 52-week low $2.26
Day low $2.55 Volume 773,090
Day high $2.69 Avg. volume 2,698,723
50-day MA $2.98 Dividend yield N/A
200-day MA $3.11 Market Cap 55.90M

Arcadia Biosciences, Inc. (RKDA) Company Bio


Arcadia Biosciences, Inc. develops and commercializes agricultural products that enhance the environment and human health. It offers crop productivity and product quality traits for various crops. The company was founded in 2002 and is based in Davis, California.


RKDA Latest News Stream


Event/Time News Detail
Loading, please wait...

RKDA Latest Social Stream


Loading social stream, please wait...

View Full RKDA Social Stream

Latest RKDA News From Around the Web

Below are the latest news stories about Arcadia Biosciences Inc that investors may wish to consider to help them evaluate RKDA as an investment opportunity.

Arcadia Biosciences (RKDA) Receives Health Canada Approval for GoodHemp™ Varieties

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced that three of its GoodHemp™ varieties have earned approval from Health Canada for their consistency and compliance. This approval follows the recent certification of GoodHemp seed varieties by the Association of Official Seed Certifying Agencies (AOSCA) and is the final step to enable hemp seed sales in Canada.

Yahoo | April 20, 2021

Arcadia Biosciences (RKDA) Acquires European Food Ingredient Platform that Further Enhances its GoodWheat™ Business

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced it has acquired, through Arcadia SPA, S.L., the assets of Agrasys S.A, a food ingredients company based in Barcelona, Spain. The transaction includes the physical and intellectual property assets to enable Arcadia to commercialize Tritordeum, a proprietary cereal grain that was developed at the Instituto de Agricultura Sostenible - Consejo Superior de Investigaciones Científicas, (IAS-CSIC) the largest public institution dedicated to agricultural research in Spain, and subsequently licensed exclusively to Agrasys for commercialization.

Yahoo | April 19, 2021

RKDA: Arcadia Biosciences is Well Funded for Management’s 2021 Growth Initiatives in GoodWheat & GoodHemp; Also a Review of 2020 Achievements

By Steven Ralston, CFA NASDAQ:RKDA READ THE FULL RKDA RESEARCH REPORT Arcadia Biosciences (NASDAQ:RKDA) is on the cusp of meaningful revenue growth, primarily from management’s initiative into the hemp space, but also from the restructured strategic relationship with Bioceres Crop Solutions for the commercialization of HB4 soybean technology in the Central and South America. Furthermore, the

Yahoo | April 14, 2021

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q4 2020 Results - Earnings Call Transcript

Arcadia Biosciences, Inc. (RKDA) Q4 2020 Earnings Conference Call March 29, 2021 16:30 ET Company Participants Matthew Plavan - President & Chief Executive Officer Randy Shultz - Chief Technical Technology Officer Pam Haley - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Presentation Operator Good afternoon...

SA Transcripts on Seeking Alpha | March 31, 2021

34 Stocks Moving in Wednesday's Pre-Market Session

Gainers Arcadia Biosciences, Inc. (NASDAQ: RKDA ) rose 52% to $3.54 in pre-market trading after the company announced better-than-expected Q4 sales. ClearOne, Inc. (NASDAQ: CLRO ) rose 29.9% to $4.00 in pre-market trading. ClearOne shares fell over 6% on Tuesday after the company reported Q4 earnings results. X Financial (NYSE: XYF ) rose 20% to $4.02 in pre-market trading after gaining around 10% on Tuesday. Hywin Holdings Ltd. (NASDAQ: HYW ) shares rose 16.5% to $11.40 in pre-market trading. The company, last week, priced its IPO at $10 per ADS. CASI Pharmaceuticals, Inc. (NASDAQ: CASI ) rose 15.1% to $2.29 in pre-market trading. The company, on Tuesday, reported FY20 results.. ProPhase Labs, Inc. (NASDAQ: PRPH ) rose 14.5% to $7.18 in pre-market trading after the company disclosed th...

Benzinga | March 31, 2021

Read More 'RKDA' Stories Here

RKDA Price Returns

1-mo -2.96%
3-mo -24.06%
6-mo -20.12%
1-year -34.83%
3-year -86.80%
5-year -94.84%
YTD 3.56%
2020 -53.83%
2019 72.87%
2018 -42.36%
2017 -70.11%
2016 -69.74%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.1627 seconds.